Diarrhea-predominant Irritable Bowel Syndrome Clinical Trial
Official title:
Traditional Chinese Medicine Tong-Xie-Yao-Fang Granules for Diarrhea-predominant Irritable Bowel Syndrome: a Randomized Placebo-controlled Trial and a Mechanistic Study
The purpose of this study is to test the efficacy and safety of a traditional Chinese medication Tong-Xie-Yao-Fang for patients with diarrhea-predominant irritable bowel Syndrome (IBS-D).
Participants: The sample size of this trial is 118, to test an odds ratio of 3.5 at a
significance of 0.05 and power of 0.8.
Intervention: Tong-Xie-Yao-Fang versus placebo Data collection: Standard operation procedure
will be developed for how to interviewing the participants, how to use the IBS diary, how to
enter the data into the electronic case report forms.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04095988 -
Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
|
N/A | |
| Completed |
NCT01736423 -
A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome
|
Phase 3 | |
| Completed |
NCT02612649 -
Special Drug Use Surveillance of Irribow in Female Patients
|
||
| Completed |
NCT01414244 -
Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
|
Phase 2 | |
| Not yet recruiting |
NCT06346847 -
Study to Assess Effects of Pasteurized Akkermansia Muciniphila vs Placebo in Participants With Diarrhea-predominant IBS
|
N/A | |
| Completed |
NCT03977155 -
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
|
Phase 2 | |
| Completed |
NCT02163213 -
Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D
|
N/A | |
| Terminated |
NCT01358708 -
Treatment of Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) With LACTEOL® 340 mg
|
Phase 3 | |
| Not yet recruiting |
NCT05687435 -
Changyanning Tablet for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
|
Phase 2/Phase 3 | |
| Completed |
NCT01870895 -
A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS)
|
Phase 3 | |
| Recruiting |
NCT05593367 -
Effects of Vitamin D on Gut Microbiota, Intestinal Barrier in IBS-D Patients
|
||
| Completed |
NCT03099785 -
Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
|
Phase 2 | |
| Recruiting |
NCT05369884 -
Efficacy and Safety of WPQW Granule for Overlap of NERD and IBS-D
|
Early Phase 1 | |
| Completed |
NCT01350570 -
Acupuncture for Patients With Diarrhea-predominant IBS or Functional Diarrhea: a Randomized Controlled Trial
|
Phase 2/Phase 3 |